Low Incidence of Invasive Fungal Infections in a Large Observational Cohort of Patients Initiating IL-17 or IL-23 Inhibitor Therapy, United States, 2016–2022
Journal of the American Academy of Dermatology（2024）
Key words
interleukin-17 inhibitors,interleukin-23 inhibitors,psoriasis,inflammatory bowel disease,Crohn’s disease,secukinumab,ixekizumab,brodalumab,ustekinumab,guselkumab,tildrakizumab,risankizumab,candidiasis,Candida infection,esophageal candidiasis,invasive fungal infection,histoplasmosis,blastomycosis,coccidioidomycosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined